XM无法为美国居民提供服务。
C
C

CaraTherapeutics

市场新闻

Cara Therapeutics Inc <CARA.OQ> expected to post a loss of 25 cents a share - Earnings Preview

Cara Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview Cara Therapeutics Inc CARA.OQ CARA.O is expected to show a fall in quarterly revenue when it reports results on November 11 (estimated) for the period ending September 30 2024 The Stamford Connecticut-based company is expected to report a 66.8% decrease in revenue to $1.616 million from $4.87 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
C

CSL Limited Reports 13.5% Stake In Cara Therapeutics

BRIEF-CSL Limited Reports 13.5% Stake In Cara Therapeutics Oct 30 (Reuters) - CSL Limited: CSL LIMITED REPORTS 13.5% STAKE IN CARA THERAPEUTICS INC AS OF OCT 23 - SEC FILING Source text: [ID:n0001193125-24-247585]
C

Cara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Cara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary Cara Therapeutics Inc CARA.OQ reported a quarterly adjusted loss of 37 cents​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of -58 cents. The mean expectation of five analysts for the quarter was for a loss of 27 cents per share.
C

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明